608
Participants
Start Date
September 1, 2021
Primary Completion Date
March 1, 2022
Study Completion Date
July 31, 2022
COVAXIN(BBV152)
COVAXIN® on day 0 and on day 28 via the intramuscular route in GROUP 1. COVAXIN® (Intramuscular) on day 0 and BBV154 (Intranasal) day 28:GROUP 2
BBV154 Intranasal Vaccine
BBV154 (Intranasal) on day 0 and COVAXIN® (Intramuscular) on day 28: GROUP 3 BBV154 on day 0 and on day 28 via the intranasal route: GROUP 4
All India Institute of Medical Scienecs, New Delhi
Malla Reddy Narayana Multispeciality Hospital, Hyderabad
The INCLEN Trust International/Guru Nanak Hospital, Gurgaon
JSS Medical College & Hospital, Mysore
Gillurkur Multispeciality Hospital, Nagpur
Institute of Medical Sciences and SUM Hospital,Odisha, Bhubaneswar
Gleneagles Global Hospitals,Hyderabad, Hyderabad
St Theresas Hospital, Hyderabad
Prakhar Hospital Pvt Limited, Kanpur
The Medicity Hopsital, Rudrapur
Institute of Liver and Biliary Sciences,New Delhi, Delhi
Bharat Biotech International Limited
INDUSTRY